Covered recipient · General Payments record
CAROLINE KINGSTON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$727.00
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $324.44 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $138.58 | 19 |
| Acerta Pharma LLC | $39.78 | 2 |
| Astellas Pharma US Inc | $28.13 | 1 |
| IBSA Pharma Inc. | $26.44 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.91 | 1 |
| Phathom Pharmaceuticals, Inc. | $19.38 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.05 | 1 |
| Exact Sciences Corporation | $17.02 | 1 |
| PFIZER INC. | $15.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.13 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079016 | CMS |
| ABBVIE INC. | $9.12 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079018 | CMS |
| ABBVIE INC. | $7.26 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079020 | CMS |
| ABBVIE INC. | $8.63 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079022 | CMS |
| ABBVIE INC. | $9.27 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079024 | CMS |
| ABBVIE INC. | $3.23 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079026 | CMS |
| ABBVIE INC. | $18.89 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079028 | CMS |
| ABBVIE INC. | $7.78 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079030 | CMS |
| ABBVIE INC. | $6.79 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079032 | CMS |
| ABBVIE INC. | $5.92 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079034 | CMS |
| ABBVIE INC. | $4.77 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079036 | CMS |
| ABBVIE INC. | $5.12 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079038 | CMS |
| ABBVIE INC. | $5.26 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079040 | CMS |
| ABBVIE INC. | $3.94 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079042 | CMS |
| ABBVIE INC. | $5.84 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079044 | CMS |
| ABBVIE INC. | $5.00 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079046 | CMS |
| ABBVIE INC. | $5.29 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079048 | CMS |
| ABBVIE INC. | $6.14 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079050 | CMS |
| ABBVIE INC. | $6.20 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104079052 | CMS |
| Astellas Pharma US Inc | $28.13 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139298526 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.92 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105783658 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.86 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105598415 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.91 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118139432 | CMS |
| Exact Sciences Corporation | $17.02 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114736293 | CMS |
| IBSA Pharma Inc. | $26.44 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974749 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.05 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118922557 | CMS |
| PFIZER INC. | $15.15 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132003128 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.38 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151082391 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.